DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gujarat Alkalies and Chemicals Limited — Investor Presentation

NSE 2 hrs ago·7 Nov 2026, 2:20 pm

Gujarat Alkalies and Chemicals

Gujarat Alkalies and Chemicals Limited (GUJALKALI) has announced the release of its investor presentation, which provides an in-depth look at the company's current business performance and future outlook. This document is typically used by management to communicate strategic plans, financial targets, and operational highlights to the market.

For investors, this update is a key source of information to gauge the company's direction. It offers insights into management's confidence in their growth trajectory and helps in assessing the company's health beyond just the quarterly results. It is a tool for retail investors to understand the roadmap for the business.

Investors should pay close attention to the management commentary regarding demand for their products, cost control measures, and any guidance provided for the upcoming quarters. This information will be crucial for evaluating the company's potential in the current market environment.